Lazard Asset Management LLC Sorrento Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $29,769 - $73,619	40,229 New	40,229 $35,000
Q2 2022 Aug 09, 2022	BUY	$1.24 - $2.33 $48,977 - $92,030	39,498 New	39,498 $79,000
Q4 2020 Feb 11, 2021	SELL	$5.76 - $11.95 $10,293 - $21,354	-1,787 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $153,071 - $466,905	-24,809 Reduced 93.28%	1,787 $19,000
Q2 2020 Aug 13, 2020	SELL	$1.73 - $6.76 $4,174 - $16,311	-2,413 Reduced 8.32%	26,596 $167,000
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $45,544 - $138,082	29,009 New	29,009 $53,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.